Cargando…
Therapeutic Effect of C-C Chemokine Receptor Type 1 (CCR1) Antagonist BX471 on Allergic Rhinitis
OBJECTIVE AND DESIGN: Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated inflammatory respiratory hypersensitivity characterized by elevated Th2 cytokines and infiltration of inflammatory cells to nasal tissues. BX471 is a small-molecule C-C chemokine receptor type 1 (CCR1) antagonist invo...
Autores principales: | Feng, Suoyi, Ju, Longzhu, Shao, Ziqi, Grzanna, Mark, Jia, Lu, Liu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398876/ https://www.ncbi.nlm.nih.gov/pubmed/32801828 http://dx.doi.org/10.2147/JIR.S254717 |
Ejemplares similares
-
Effects of blocking chemokine receptor CCR1 with BX471 in two models of fibrosis prevention and rescue in mice
por: Weber, Susanne N., et al.
Publicado: (2021) -
Effects of a dual CCR3 and H(1)-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis
por: Greiff, Lennart, et al.
Publicado: (2010) -
Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor
por: Tsou, Chia-Lin, et al.
Publicado: (1998) -
The Relationship between Chemokine Ligand 3 and Allergic Rhinitis
por: Berghi, Ovidiu, et al.
Publicado: (2020) -
Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
por: Lukacs, Nicholas W., et al.
Publicado: (2001)